E. coli Expression
WELCOME TO ACCELAGEN
Accelagen is a fast growing Gene-to-Protein company providing superior quality services and products. The Accelagen team has demonstrated independent research capability in many projects and provided innovative solutions. Our scientists have extensive experiences in production of antibodies, GPCRs, kinases, nuclear receptors, and many other classes of drug targets and therapeutic proteins. Accelagen has established an unsurpassed track record of timely completion of projects over the years.
Accelagen contract services provide a comprehensive gene-to-protein solution. Our recombinant protein expression and purification services have yielded premium quality recombinant proteins for drug discovery. We have produced recombinant proteins for determination of co-crystal structures in Structure-Based Drug Discovery (SBDD), for assays in high-throughput screening (HTS) and lead development, and for pre-clinical animal studies.
Accelagen’s gene-to-protein platform integrates the latest technologies of Baculovirus Expression Vector System (BEVS), E. coli expression, mammalian expression, Wave Bioreactors, Cell Factory, and AKTA chromatography systems for protein purificaiton. We have achieved superior protein quality and accelerated the processes from gene to protein. This platform is validated in the quality of our products and by the successes of our customers.
Our mission is to provide cost-effective gene-to-protein services, through technical excellence and quality communication.
Our price is competitive. Your success is priceless.
For more information on how we can accelerate your success, contact us now.